Back

Decrease in multiple complement protein levels is associated with the development of islet autoimmunity and type 1 diabetes

Webb-Robertson, B.-J. M.; Nakayasu, E. S.; Dong, F.; Waugh, K.; Flores, J.; Bramer, L.; Schepmoes, A.; Gao, Y.; Fillmore, T.; Onengut-Gumuscu, S.; Frazer-Abel, A.; Rich, S.; Holers, M.; Metz, T.; Rewers, M.

2023-07-16 endocrinology
10.1101/2023.07.13.23292628 medRxiv
Show abstract

Type 1 diabetes (T1D) is a chronic condition caused by autoimmune destruction of the insulin-producing pancreatic {beta}-cells. While it is known that gene-environment interactions play a key role in triggering the autoimmune process leading to T1D, the pathogenic mechanism leading to the appearance of islet autoantibodies - biomarkers of autoimmunity - is poorly understood. Here we show that disruption of the complement system precedes the detection of islet autoantibodies and persists through disease onset. Our results suggest that children who exhibit islet autoimmunity and progress to clinical T1D have lower complement protein levels relative to those who do not progress within a similar timeframe. Thus, the complement pathway, an understudied mechanistic and therapeutic target in T1D, merits increased attention for use as protein biomarkers of prediction and potentially prevention of T1D.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.